Keyphrases
Fibroblast Growth Factor 23 (FGF23)
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
100%
Exercise Capacity
100%
Patients with Heart Failure
14%
Left Ventricular Hypertrophy
14%
6-minute Walk Distance (6MWD)
14%
Maximal Oxygen Uptake
14%
Cardiovascular Disease
7%
Phosphate
7%
Phosphodiesterase Type 5 Inhibitors
7%
Vitamin D
7%
Longitudinal Outcomes
7%
Clinical Status
7%
Iron Homeostasis
7%
Linear Mixed Model
7%
Multivariate Linear Regression
7%
Clinical Exercise
7%
Hematologic Parameters
7%
Kidney Parameters
7%
Medicine and Dentistry
Exercise
100%
Heart Failure with Preserved Ejection Fraction
100%
Fibroblast Growth Factor 23
100%
Left Ventricular Hypertrophy
14%
Oxygen Consumption
14%
Cardiovascular Disease
7%
Population Research
7%
Linear Regression Analysis
7%
Mixed Model
7%
Phosphodiesterase V
7%
Iron Homeostasis
7%
Vitamin D
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure with Preserved Ejection Fraction
100%
Fibroblast Growth Factor 23
100%
Heart Left Ventricle Hypertrophy
14%
Population Study
7%
Mixed Model
7%
Phosphodiesterase V
7%
Vitamin D
7%
Cardiovascular Disease
7%